University of Minnesota. Driven to Discover.
Skepticism remains in some high-income nations, with France having the lowest trust in vaccines.
The WHO is stepping up its response in Europe, as cases surge in Tunisa and researchers plot at-risk US sites.
Japanese researchers describe two H3N2 flu viruses with mutations that may increase antiviral resistance.
More than 100 governments, drug firms, and others have already made commitments.
Baloxavir reduced flu symptoms by 1 day and reduced viral shedding.
The strain has 2 mutations that might alter its susceptibility to the neuraminidase inhibitor class of antiviral drugs.
The strain resulted from a mix of high-path H5N8 and low-path H3N6.
Farmers in France's foie gras region will halt production for 6 weeks.
Japan, meanwhile, reports two large H5N6 outbreaks at poultry farms in different prefectures.
H5N8 has now been confirmed in 40 countries, and South Korean scientists shared genetic findings from a recent H5N6 isolate.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.